Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 25981-25990 Newer>

The Motley Fool September 8, 2007 Rick Aristotle Munarriz	The Fool's Look Ahead These companies will be reporting earnings this week: Shuffle Master... Globecomm... Brady... CHC Helicopter...
The Motley Fool September 7, 2007 Lawrence A. Rothman	No Froth for Stein Mart Comps are on the slide, even more than analysts expected, as competitors appear to be gaining the upper hand.
The Motley Fool September 7, 2007 Ryan Fuhrmann	Could Subprime Save Fleetwood? First-quarter results came in slightly ahead of pessimistic analyst projections at the manufactured home and RV maker. Looking forward, management feels the current subprime challenges could actually end up helping its housing segment.
The Motley Fool September 7, 2007 Ryan Fuhrmann	Keepin' Watch on Movado At the current share price, an investment in watch maker Movado in 2000 would have netted Fools almost eight times their original investment. And judging by today's second-quarter results, it could soon turn into a coveted 10-bagger.
The Motley Fool September 7, 2007 Lawrence A. Rothman	Quiksilver's Not Riding the Right Wave Quiksilver earnings tumbled 50% from one year ago in the third quarter. The company is struggling to manage the brands it owns, such as Rossignol and Roger Cleveland Golf Company.
The Motley Fool September 7, 2007 Rich Smith	Russian Telecom Springs a Leak MTS, Russia's largest cell-phone operator, reports strong second-quarter earnings, however, there are fears of cell-phone saturation in Russia and neighboring Ukraine.
The Motley Fool September 7, 2007 Seth Jayson	Wall Street Gets Its Wish Will the lackluster jobs report from the Bureau of Labor Statistics get the Fed's attention, and maybe scare it into a quarter or half-point cut?
The Motley Fool September 7, 2007 Ryan Fuhrmann	Mr. Market Drops Cascade Despite healthy growth domestically and abroad, stock prices at the forklift products manufacturer are down after second-quarter reports. Investors, does this represent an opportunity for you?
The Motley Fool September 7, 2007 Brian Orelli	Merck Says No to This Protein An FDA advisory panel recommends unanimous approval of a new HIV drug from Merck. The new class of HIV medications fight the virus by blocking one key protein from entering cells.
The Motley Fool September 7, 2007 Katrina Chan	Ask.com Seeking Better Algorithm The search site still lacks the right stuff. Ask.com could not separate websites from other search results, nor could it filter out duplicate articles from the same source.
<Older 25981-25990 Newer> Return to current articles.